These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21284243)

  • 1. Back to school.
    Blow NS
    Biotechniques; 2011 Jan; 50(1):19-21. PubMed ID: 21284243
    [No Abstract]   [Full Text] [Related]  

  • 2. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
    Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
    Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening methods for ion-channels drug discovery and new ideas].
    Fujii M; Ohya S; Yamamura H; Imaizumi Y
    Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):229-33. PubMed ID: 22156258
    [No Abstract]   [Full Text] [Related]  

  • 4. The University of Kansas High-Throughput Screening Laboratory. Part II: enabling collaborative drug-discovery partnerships through cutting-edge screening technology.
    McDonald PR; Roy A; Chaguturu R
    Future Med Chem; 2011 Jul; 3(9):1101-10. PubMed ID: 21806374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput screening operations at the University of Kansas.
    Roy A
    Comb Chem High Throughput Screen; 2014 May; 17(4):387-93. PubMed ID: 24661207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of Strategic Small-Scale Targeted Screening.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Aug; 14(6):329-32. PubMed ID: 27341343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge from Small-Molecule Screening and Profiling Data.
    Green DV; Clemons PA
    J Biomol Screen; 2014 Jun; 19(5):611-3. PubMed ID: 24842910
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The University of Kansas High-Throughput Screening laboratory. Part I: meeting drug-discovery needs in the heartland of America with entrepreneurial flair.
    McDonald PR; Roy A; Chaguturu R
    Future Med Chem; 2011 May; 3(7):789-95. PubMed ID: 21644824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Institutes of Health. Drug-screening program looking for a home.
    Kaiser J
    Science; 2011 Oct; 334(6054):299. PubMed ID: 22021828
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress and new fields in molecular pharmacology.
    Boutin JA
    Curr Opin Pharmacol; 2009 Oct; 9(5):577-9. PubMed ID: 19726229
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening.
    Eglen R; Reisine T
    Assay Drug Dev Technol; 2011 Apr; 9(2):108-24. PubMed ID: 21186936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment-based approaches in drug discovery and chemical biology.
    Scott DE; Coyne AG; Hudson SA; Abell C
    Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new phenotypic lexicon for accelerated translation: rise of the machines.
    MacRae CA
    Circulation; 2015 Jan; 131(3):234-6. PubMed ID: 25601949
    [No Abstract]   [Full Text] [Related]  

  • 16. Twenty years on: the impact of fragments on drug discovery.
    Erlanson DA; Fesik SW; Hubbard RE; Jahnke W; Jhoti H
    Nat Rev Drug Discov; 2016 Sep; 15(9):605-619. PubMed ID: 27417849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Screening Asia Conference 2010: an update.
    Chaguturu R
    Future Med Chem; 2011 Apr; 3(5):513-7. PubMed ID: 21526893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The why and how of phenotypic small-molecule screens.
    Eggert US
    Nat Chem Biol; 2013 Apr; 9(4):206-9. PubMed ID: 23508174
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating and evolving a screening library in academia: the St Jude approach.
    Nishiguchi G; Das S; Ochoada J; Long H; Lee RE; Rankovic Z; Shelat AA
    Drug Discov Today; 2021 Apr; 26(4):1060-1069. PubMed ID: 33453364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical screening in zebrafish for novel biological and therapeutic discovery.
    Tan JL; Zon LI
    Methods Cell Biol; 2011; 105():493-516. PubMed ID: 21951544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.